Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma · 2024-03 · Volume 11 · 581-594
DOI: 10.2147/jhc.s450460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Hepatocellular Carcinoma, 2024-03. Verfasst von Pinggui Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyu…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the sixth most common cancer globally and the primary cause of death in cancer cases, with significant public health concern worldwide. Despite the overall decline in the incidence and mortality rates of HCC in recent years in recent years, the emergence of metabolic liver disease-related HCC is causing heightened concern, especially in countries like the United States, the United Kingdom, and P.R. China. The escalation of metabolic liver disease-related HCC is attributed to a combination of factors, including genetic predisposition, lifestyle choices, and changes in the living environment. However, the pathogenesis of metabolic liver disease-associated HCC remains imperfect. In this review, we encapsulate the latest advances and essential aspects of the pathogenesis of metabolic liver disease-associated HCC, including alcoholic liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD), and inherited metabolic liver diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, People's Republic of China.
- Department of School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
ORCID-Profile: Pinggui Chen, Yunyan Dai, Yunpeng Zhou, Yi Wang
Zitieren
APA
Chen, P., Li, Y., Dai, Y., Wang, Z., Zhou, Y., Wang, Y., & Li, G. (2024). Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 11, 581-594. https://doi.org/10.2147/jhc.s450460
Vancouver
Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, et al. Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2024;Volume 11:581-594. doi:10.2147/jhc.s450460
BibTeX
@article{Chen2024,
author = {Chen, Pinggui and Li, Yaoxuan and Dai, Yunyan and Wang, Zhiming and Zhou, Yunpeng and Wang, Yi and Li, Gaopeng},
title = {Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma},
journal = {Journal of Hepatocellular Carcinoma},
year = {2024},
volume = {Volume 11},
pages = {581--594},
doi = {10.2147/jhc.s450460}
}
EUVIMED